Clinical Trial Update: Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating metabolic imaging of the heart with hyperpolarized carbon-13 pyruvate; recruitment is ongoing. The study targets patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Hyperpolarized [13C] Pyruvate imaging agent (pyruvate (hyperpolarized carbon-13))

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Hypertension, Hypertrophy | Phase 1 | Status: RECRUITING